Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
暂无分享,去创建一个
Fei Liu | D. Rubin | Minhu Chen | W. Sandborn | Baili Chen | Xiang Chen | R. Drozda | Feng Pan | Xiang Sun | A. Goh | Jie Zhong | Yi-juan Ding | Zhenyu Zhang | Yan Zhang | Hong Chen | Oleksandr Oliinyk | Ling Zhang | Xiuling Li